The purpose of this research was to investigate the effects of BITG on immune response in the young mice. BITG(500mg/kg) was administerd per orally once a day for 7 days to the young BALB/C(4 wks old)mice. The administrationo of BITG enhanced the cell viability of splenocytes, but did not affect that of thymocytes. In vitro system, BITG decreased the cell viability of thymocytes and splenocytes at the concentration of $100{mu}g/m{ell}$. The administration of BITG did not affect DNA fragmentation of thymocytes, but decreased that of splenocytes. The administration of BITG increased the population of Thy1+ cell and CD4+CD8- cell in splenocytes. In addition, BITG decreased the production of NO and increased the lucigenin chemiluminescence from peritoneal macrophages. These results suggest that BITG enhances the specific-immune and nonspecific-immune response via increase of cell viability in splenocytes and of phagocytic activity in peritoneal macrophages.